학술논문

Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective
Document Type
Academic Journal
Source
Breast Cancer Research and Treatment. January, 2023, Vol. 197 Issue 1, p83, 10 p.
Subject
Medical research -- Analysis
Medicine, Experimental -- Analysis
Patient satisfaction -- Analysis
Lymphedema -- Care and treatment
Cancer -- Care and treatment
Breast cancer -- Care and treatment
Surgery -- Analysis
Language
English
ISSN
0167-6806
Abstract
Purpose We investigated whether a one-stage combination of vascularized lymph node transfer (VLNT) with water jet-assisted liposuction (WAL) can be safely performed and results in improved patient outcomes such as a greater reduction in arm volume when treating chronic breast cancer-related lymphedema (BCRL). Methods In this retrospective cohort study, we included all patients from our encrypted lymphedema database treated for chronic BCRL with VLNT or VLNT + WAL who had a minimum follow-up of two years. We analyzed patient-specific variables including arm circumferences as well as patient-reported outcomes before and after surgery as well as surgery time, surgery-related complications and patient satisfaction. Results Only the mean preoperative differences of the circumferences between the lymphedematous and the unaffected arm in individual patients showed a statistically significant difference between treatment groups (p < 0.05). Indeed, patients treated with VLNT + WAL had consistently larger differences in individual sets of arms and therefore more pronounced chronic BCRL. The mean surgery time was significantly longer in the VLNT + WAL group (p < 0.05). Complications were seldom and similar in both groups. Using a numeric rating scale, the level of patient satisfaction following treatment did not differ significantly between groups (p = 0.323). Conclusions Our findings suggest that a one-stage combination of VLNT with WAL does not result in more complications even though it also entails a longer surgery time. This is acceptable as secondary interventions resulting in overall longer surgery times and higher costs can be avoided. A one-stage combination might be especially favourable for patients suffering from more severe chronic BCRL.
Author(s): Alina A. Ghazaleh [sup.1], Tristan M. Handschin [sup.3] [sup.4], Julia Buckowiecki [sup.1], Frédérique S. Chammartin [sup.5], Christoph Andree [sup.2], Dirk J. Schaefer [sup.3] [sup.4], Martin Haug [sup.3] [sup.4] [sup.6], [...]